Skip to main content

Table 3 Lifetime medical expenditure for patients with lung cancer

From: Lifetime survival and medical costs of lung cancer: a semi-parametric estimation from South Korea

USDa (Standard error)

Patients with lung cancer

Cost ratio B to A

Yearly medical cost (YMC) in USD

MEb (A)

eMEc (B)

Total (n = 2919)

22,130 (506)

30,857 (1156)

1.39

5393 (399)

Surgery (n = 426)

30,843 (1147)

61,592 (4722)

2.00

4359 (434)

Surgery+CTx/RTx (n = 296)

42,384 (1699)

60,640 (4894)

1.43

7075 (1012)

CTx/RTx (n = 1405)

25,255 (578)

30,079 (1261)

1.19

7626 (756)

BSC (n = 792)

5562 (187)

NA

–

12,042 (560)

  1. BSC best supportive care, CTx/RTx chemotherapy and/or radiation therapy, eME estimated medical expenditure, ME medical expenditure
  2. aApplied exchange rate: 1100 Korea Won/USD
  3. bActual medical expenditure based on real data analysis during a 100-month follow-up period
  4. cEstimated medical expenditure based on the actual expenditure during the real follow-up period (100 months) and extrapolated costs for the next 200 months
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us